The Clorox Company (NYSE:CLX) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its position in The Clorox Company (NYSE:CLX) by 3.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,335 shares of the company’s stock after selling 502 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Clorox were worth $2,111,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Redwood Park Advisors LLC acquired a new position in Clorox during the 4th quarter worth $26,000. Millstone Evans Group LLC purchased a new stake in Clorox during the 4th quarter worth about $31,000. Wood Tarver Financial Group LLC purchased a new stake in Clorox during the 4th quarter worth about $31,000. GKV Capital Management Co. Inc. purchased a new stake in Clorox during the 4th quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in Clorox during the 4th quarter worth about $33,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the firm’s stock in a transaction on Wednesday, May 7th. The stock was bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director directly owned 4,000 shares of the company’s stock, valued at approximately $546,280. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Performance

Shares of NYSE CLX opened at $128.28 on Friday. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The company has a market cap of $15.81 billion, a PE ratio of 23.03, a P/E/G ratio of 3.37 and a beta of 0.51. The stock has a 50 day simple moving average of $127.36 and a 200-day simple moving average of $141.21. The company has a current ratio of 0.74, a quick ratio of 0.44 and a debt-to-equity ratio of 13.07.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the company posted $1.71 EPS. Clorox’s quarterly revenue was down 8.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Morgan Stanley reduced their target price on Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Jefferies Financial Group dropped their target price on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. Wells Fargo & Company lowered their price target on Clorox from $142.00 to $135.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 9th. Barclays set a $119.00 price target on Clorox and gave the stock an “underweight” rating in a report on Tuesday, July 15th. Finally, Citigroup reiterated a “neutral” rating and set a $135.00 target price (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $145.17.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.